Statistics
Publications
25
Citations
6.8K
H-Index
19
Active since
2013
V.P. Stus is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, oncology, and cancer pharmacology.
Publications per year
2013–2025
25
25
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini, Elizabeth R. Plimack, V.P. Stus et al. · New England Journal of Medicine · 2019 · 3.4K citations · Full text
Medicine, Oncology, Pharmacology +9
Thomas Powles, Elizabeth R. Plimack, Denis Soulières et al. · The Lancet Oncology · 2020 · 745 citations
Medicine, Oncology, Pharmacology +13
J. Motsch, Cláudia Murta de Oliveira, V.P. Stus et al. · Clinical Infectious Diseases · 2019 · 404 citations · Full text
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
Kim N., Dana E. Rathkopf, Matthew R. Smith et al. · Journal of Clinical Oncology · 2023 · 319 citations · Full text
1–5 of 25